Esopram Filmuhúðuð tafla 15 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

esopram filmuhúðuð tafla 15 mg

teva b.v.* - escitalopramum oxalat - filmuhúðuð tafla - 15 mg

Esopram Filmuhúðuð tafla 20 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

esopram filmuhúðuð tafla 20 mg

teva b.v.* - escitalopramum oxalat - filmuhúðuð tafla - 20 mg

Esopram Filmuhúðuð tafla 5 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

esopram filmuhúðuð tafla 5 mg

teva b.v.* - escitalopramum oxalat - filmuhúðuð tafla - 5 mg

Oropram Filmuhúðuð tafla 10 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

oropram filmuhúðuð tafla 10 mg

teva b.v.* - citalopram hydrobromide - filmuhúðuð tafla - 10 mg

Oropram Filmuhúðuð tafla 20 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

oropram filmuhúðuð tafla 20 mg

teva b.v.* - citalopram hydrobromide - filmuhúðuð tafla - 20 mg

Oropram Filmuhúðuð tafla 40 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

oropram filmuhúðuð tafla 40 mg

teva b.v.* - citalopram hydrobromide - filmuhúðuð tafla - 40 mg

Sotalol Viatris (Sotalol Mylan) Tafla 40 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

sotalol viatris (sotalol mylan) tafla 40 mg

viatris limited - sotalolum hýdróklóríð - tafla - 40 mg

Sotalol Viatris (Sotalol Mylan) Tafla 80 mg Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

sotalol viatris (sotalol mylan) tafla 80 mg

viatris limited - sotalolum hýdróklóríð - tafla - 80 mg

Camzyos Európai Unió - izlandi - EMA (European Medicines Agency)

camzyos

bristol-myers squibb pharma eeig - mavacamten - cardiomyopathy, hypertrophic - Önnur hjartablöndur - treatment of symptomatic obstructive hypertrophic cardiomyopathy.

Cabometyx Európai Unió - izlandi - EMA (European Medicines Agency)

cabometyx

ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - Æxlishemjandi lyf - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.